All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
A unique cure for cancer has been created in Pennsylvania
Last reviewed: 02.07.2025
Palbociclib is a new drug that scientists claim is a universal medicine for breast cancer. The developers said that the new drug is capable of not only stopping the growth of malignant tumors, but also helps to reduce them at any stage of the disease.
Experts noted that the new drug can be prescribed both in combination with endocrine therapy and as an independent treatment, and its effectiveness will not decrease.
According to the studies, Palbociclib copes well with lymphoma, sarcoma, teratoma.
The new drug works by inhibiting the growth of cancer cells. Palbociclib interferes with the ability of atypical cells to divide rapidly by inhibiting the activity of certain enzymes that stimulate cell division. According to researchers at the University of Pennsylvania, the new drug, when combined with chemotherapy or endocrine treatment, produces a powerful therapeutic effect.
Studies have shown that one dose of Palbociclib per day is safe for health, the side effect of the drug is a decrease in the level of neutrophils in the blood (white blood cells), which leads to a decrease in the body's resistance to infections. Palbociclib has little effect on normal cells. The developers of the new drug themselves claim that their drug helps slow down the growth of a cancerous tumor or completely stop it.
Another research group from the University of Montreal has developed a unique method of treating cancer using a biological gel that is injected into the body. The biogel destroys cancer cells and laboratory studies have confirmed its effectiveness. The anti-cancer biogel has shown good results in laboratory studies on kidney cancer and melanoma models, and scientists have already begun clinical trials involving humans.
According to scientists, if the biogel proves its effectiveness, then the unique treatment technology will help cure various forms of cancer, and scientists confidently give a 100% guarantee.
The new biogel is also called smart, because at room temperature it is liquid, but when it enters the human body, the liquid begins to turn into a gel. The experts made the compound from chitosan (a biodegradable material obtained from the shells of crabs, lobsters, etc.) and a special gel substance.
The therapeutic effect of the "smart" gel can be compared to anti-cancer immune cells. The developers use an innovative means to program cells. The drug is administered using a syringe, which allows the drug to be administered directly into the cancerous tumor or into nearby areas.
This therapy provides targeted action on the source of the disease - other drugs are introduced into the bloodstream and spread throughout the body, while biogel allows you to act directly on the tumor. It is worth noting that this method can be considered a real breakthrough in immunotherapy.
[ 1 ]